ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy.

Saved in:
Bibliographic Details
Title: ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy.
Authors: Filzmayer M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada. filzmayer@med.uni-frankfurt.de.; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany. filzmayer@med.uni-frankfurt.de., Nicolazzini M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada.; Division of Urology, Department of Translational Medicine, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy.; Division of Urology, Department of Oncology, University of Turin, Orbassano, Italy., Catanzaro C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada.; Department of Urology, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy., Polverino F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Petix M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada.; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Quarta L; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada.; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Goyal JA; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada., Volpe A; Division of Urology, Department of Translational Medicine, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy., Schiavina R; Department of Urology, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy., Longo N; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Musi G; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Briganti A; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Hourani Center of Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan., Wenzel M; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Kosiba M; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Humke C; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada., Chun FK; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montréal, QC, Canada.
Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Jun; Vol. 33 (6), pp. 5908-5909. Date of Electronic Publication: 2026 Mar 06.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-026-19381-y